TSX open
Loading markets…

Advertisement

Stocks

Why Cipher Pharmaceuticals Inc stock is sliding today

By Wealth Awesome -

This move is archived. Current quotes and coverage live on the stock page.

Stocks & ETFs:CPH.TO

Follow CPH

Photos provided by Pexels

Cipher Pharmaceuticals Inc is experiencing a significant decline, with its stock price dropping 3.09% in the last trading session.

In the latest trading session, Cipher Pharmaceuticals Inc (CPH.TO) saw its stock price slide to CA$16.00, marking a 3.09% decrease. This decline comes despite recent positive financial reports, raising questions about investor sentiment and market dynamics.

Advertisement

Cipher Pharmaceuticals Inc

CPH.TO

Full stock page →

CPH.TO

Cipher Pharmaceuticals Inc

Source:WealthAwesomeWealthAwesome
↓ $4.53 (-24.10%)
120 day period
$13.68$16.71$19.74Apr 2Jun 29Sep 23

Market cap

$362.67M

P/E

9.1x

52W high

$20.56

52W low

$12.48

1W change

-1.65%

Beta

0.40

Analyst Price Targets

Based on analyst covering CPH · as of Sep 23, 2026

📈

Wall Street analysts forecast CPH stock price to rise 36.3% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$19.45

+36.3% Upside

Previously C$19.95 on Sep 17, 2026

Current Price

C$14.27

Last close

Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on CPH's historical volatility

HistoricalForecast68%95%
C$4.80C$9.77C$14.74C$19.71C$24.68C$29.65TodayMay 15Jul 21Sep 23Nov 5Dec 19Jan 31

30-Day Vol

73.7%

Annualized

90-Day Vol

46.4%

Annualized

Trend (90d)

-50.0%

Annualized drift

90d Mean

C$11.94

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$13.45C$10.43 – C$17.34
60 trading daysC$12.67C$8.84 – C$18.15
90 trading daysC$11.94C$7.69 – C$18.54

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Advertisement

Investor takeaway: Investors should consider the broader market context and recent performance trends when evaluating Cipher Pharmaceuticals, especially in light of its recent stock slide.

3.09% Decline in One Day

Cipher Pharmaceuticals' stock fell to CA$16.00, highlighting investor caution amid fluctuating market conditions.

Bull case

Cipher Pharmaceuticals has demonstrated strong financial growth in previous quarters, with significant increases in revenue and net income. This suggests there’s potential for recovery, especially if the market stabilizes and investor confidence returns.

Bear case

The recent drop in stock price signals potential investor concerns. This could be linked to market volatility or broader economic factors impacting the pharmaceutical sector. Investors should be aware of these risks as they consider their options.

Market Overview

Advertisement

On the last trading day, Cipher Pharmaceuticals Inc's stock closed at CA$16.00, reflecting a 3.09% decrease. This decline is noteworthy given the company's recent financial performance, which included a substantial increase in revenue and net income reported earlier this year.

Recent Performance Context

Despite Cipher Pharmaceuticals reporting impressive growth metrics, including a 25% increase in adjusted EBITDA in Q1 2026, the stock's recent slide suggests that investors are reacting to broader market trends or specific concerns regarding the pharmaceutical sector. For more details on their financials, check out our analysis on Cipher Pharmaceuticals.

Investor Sentiment

The 3.09% drop in stock price could indicate a shift in investor sentiment. While Cipher has shown strong financials, the market's reaction may reflect caution amid potential economic uncertainties. Investors should monitor upcoming earnings reports and market conditions closely.


Advertisement

Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile →

✅ Reviewed by Certified Financial Professionals

This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

📊 Data AccuracyVerified sources
🇨🇦 Canadian FocusLocal expertise
🔍 Fact-CheckedEditorial review

⚠️ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: June 11, 2026
Last Updated: June 11, 2026

Core portfolio

Awesome Portfolio™

15.1% a year since 2017, against 9.9% for the S&P/TSX Composite. Ten stocks, easy to manage. We update it once a month.

Annualized

+15.1%

Awesome Portfolio™

+9.9%

S&P/TSX

+5.2 pp better a year

Total return

+260%

Awesome Portfolio™

+137%

S&P/TSX

+123 pp better than the TSX

2017-07-31 to 2026-09-17, dividends reinvested, before fees and tax.

Awesome Portfolio™S&P/TSX CompositeCumulative return · 2017-07-31–2026-09-17
-11.7%42.8%97.2%151.6%206.0%260.4%Jul 17Oct 19Feb 22Jun 24Sep 26

Sponsored links

Advertisement